UnknownNot Applicable

The Role of Active Administration of Peristeen Bowel Evacuation for the Management of Urinary Tract Infection

South Korea20 participantsStarted 2021-04-14

Plain-language summary

This study investigates whether active use of transanal irrigation (Peristeen®) effectively manages urinary tract infection among patients with the diagnosis of neurogenic bladder.

Who can participate

Age range5 Years – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Anorectal malformation
✕. Colorectal cancer
✕. Endoscopic polyp removal surgery in 3 months
✕. Ischemic colitis
✕. Acute inflammatory bowel disease
✕. Acute intestinal diverticulum.
✕. Radiotherapy to the colon
✕. Long-term corticosteroid usage

What they're measuring

Change in nitrite and leukocyte esterase

Timeframe: Baseline

Change in nitrite and leukocyte esterase

Timeframe: 4 weeks

Change in nitrite and leukocyte esterase

Timeframe: 8 weeks

Change in nitrite and leukocyte esterase

Timeframe: 12 weeks

Trial details

NCT IDNCT04815226

SponsorSeoul National University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-31

View on ClinicalTrials.gov More Neurogenic Bladder trials